Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy (Q82357642)
Jump to navigation
Jump to search
scientific article published on 01 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy |
scientific article published on 01 January 2010 |
Statements
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone (English)
Patrick Garnero
Elizabeth Thompson
Thasia Woodworth
Josef S Smolen
1 January 2010